IP Library Granted Patent US 7,039,467
Granted Patent B2
US 7,039,467 · App. 10/388,073 · Granted May 2, 2006

Therapeutic device and method for treating diseases of cardiac muscle

Assignee: EM Vascular, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,039,467
App. No.
10/388,073
Granted
May 2, 2006
Kind
B2
Abstract

An apparatus and method for conferring a therapeutic current to the heart is provided. The apparatus includes a first electrode, a second electrode, a current generator and a controller. The apparatus may further include a sensor. The sensor is generally configured to measure field strength between the first and second electrode. The sensor may also monitor the cardiac cycle. The method includes applying an electric stimulus to the heart and sensing the electric field generated by the electric stimulus to prevent the level of current from inducing unwanted depolarization.

Claims (15)

1. A method for providing cardiac therapy, comprising:

applying a stimulus to a heart, the heart positioned between a first electrode and a second electrode;

measuring the field strength generated by applying the stimulus; and

adjusting at least one parameter of the stimulus to maintain the stimulus below a depolarization threshold of the heart based on the measuring.

2. A method, as in claim 1 , further comprising:

sensing a cardiac cycle of a heart to determine a refractory period of the heart; and

applying the stimulus to the heart during the refractory period.

3. A method, as in claim 2 , further comprising adjusting at least one parameter of the stimulus to the heart based on the cardiac cycle.

4. A method, as in claim 3 , wherein the stimulus is continuously applied throughout the cardiac cycle.

5. A method, as in claim 1 , wherein measuring the field strength comprises:

inserting the sensor through an esophagus to a position adjacent the heart; and

orienting the sensor to sense a maximum field strength.

6. A method, as in claim 1 , wherein measuring the field strength comprises:

inserting the sensor into the heart; and

orienting the sensor to sense a maximum field strength.

Assignments (3)
MERGER AND CHANGE OF NAME Recorded Jul 12, 2021
From: ATS MEDICAL, INC.; PILGRIM MERGER CORPORATION
To: MEDTRONIC ATS MEDICAL, INC.
Reel/Frame 056821/0401 →
MERGER Recorded Apr 1, 2011
From: ATS MEDICAL INC; PILGRIM MERGER CORPORATION
To: MEDTRONIC ATS MEDICAL INC.
Reel/Frame 026064/0197 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2007
From: EM VASCULAR, INC.
To: ATS MEDICAL, INC.
Reel/Frame 018875/0158 →
Continuity (4)
Division 0975656700 · Jan 8, 2001
Continuation In Part 0963823300 · Aug 14, 2000
Provisional Application 6014351000 · Aug 24, 1999
Related Publication 20030163168A1 · Aug 28, 2003